Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew J. Schwab currently holds 75,000 shares of Pear Therapeutics, Inc. (PEAR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew J. Schwab has been a net seller of PEAR stock. They have purchased $15.0M and sold $56.8M worth of shares.
Andrew J. Schwab's most recent insider trade was on Mar 31, 2026, when they sold 75,000 shares at $0.00 per share.
Andrew J. Schwab serves as Executive at Pear Therapeutics, Inc. (PEAR). They have executed 82 insider transactions totaling $71.8M over their tenure at the company.
Andrew J. Schwab holds the position of Executive at Pear Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Andrew J. Schwab has shown a selling trading pattern, with $15.0M in total purchases and $56.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew J. Schwab was on Jan 31, 2024, when they purchased $12.0M worth of SKYE shares. This transaction involved 5,206,074 shares at $2.31 per share.
Andrew J. Schwab currently owns 75,000 shares of Pear Therapeutics, Inc. (PEAR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew J. Schwab's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew J. Schwab has 82 Form 4 filings on record as an insider at Pear Therapeutics, Inc..
Set alerts for Andrew J. Schwab and 40,000+ other insiders.